Brokerages Set Oscar Health, Inc. (NYSE:OSCR) PT at $21.56

Oscar Health, Inc. (NYSE:OSCR) has been assigned an average rating of “Hold” from the nine analysts that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation, four have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $21.56.

OSCR has been the topic of several research analyst reports. UBS Group began coverage on Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective on the stock. Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price target for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. Jefferies Financial Group assumed coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective on the stock. Finally, Piper Sandler reissued an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th.

Insider Buying and Selling

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $17.05, for a total value of $426,250.00. Following the completion of the transaction, the director now owns 89,512 shares in the company, valued at approximately $1,526,179.60. This trade represents a 21.83 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CAO Victoria Baltrus sold 8,078 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $146,050.24. Following the sale, the chief accounting officer now directly owns 146,036 shares in the company, valued at $2,640,330.88. The trade was a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have acquired 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. 25.11% of the stock is currently owned by company insiders.

Institutional Trading of Oscar Health

A number of institutional investors have recently bought and sold shares of the stock. Raymond James & Associates bought a new stake in shares of Oscar Health in the 2nd quarter worth about $3,168,000. Hennessy Advisors Inc. bought a new stake in Oscar Health in the second quarter worth about $9,047,000. Catalyst Capital Advisors LLC purchased a new position in shares of Oscar Health during the second quarter valued at approximately $1,535,000. Bank of New York Mellon Corp boosted its position in shares of Oscar Health by 161.4% during the second quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company’s stock valued at $22,038,000 after buying an additional 860,226 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Oscar Health by 26.9% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,210 shares of the company’s stock valued at $383,000 after buying an additional 5,138 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Price Performance

NYSE OSCR opened at $14.09 on Wednesday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health has a 12 month low of $8.14 and a 12 month high of $23.79. The stock has a market cap of $3.48 billion, a price-to-earnings ratio of -234.79 and a beta of 1.63. The company’s 50 day moving average is $15.89 and its two-hundred day moving average is $17.41.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion during the quarter, compared to analysts’ expectations of $2.33 billion. During the same period last year, the company earned ($0.29) earnings per share. The business’s revenue for the quarter was up 68.3% on a year-over-year basis. As a group, research analysts anticipate that Oscar Health will post -0.01 earnings per share for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.